New Generation Bioavailability Engineering
Next-generation biotech infrastructure — we turn bioavailability from a test result into a technology foundation that can be designed, manufactured and monetized as a product.
Engineering Bioavailability. Enabling Human Performance.
Re-engineering bioavailability to unlock human potential, turning active ingredients into verifiable commercial value.
A Platform-Scale Business
The business is comparable to the platform businesses of Lonza, Catalent, Thermo Fisher and Evonik.
A Complete Commercial Loop
From active ingredient discovery to human efficacy verification, clients complete every step with one partner.
Next-Generation Biotech Infrastructure
Not a service company, but a replicable, licensable, productizable technology infrastructure.
One Platform, Four Dimensions — peers hold one capability; we span four
Four-Part Revenue Structure
Equipment sales + reagents and consumables + software licensing + service contracts. Instruments create durable competitive moats beyond traditional CRO models.
Equipment Sales
Five self-developed systems plus the MS sample-preparation line.
Reagents and Consumables
Sample-prep plates, kits and preservation solutions with recurring demand.
Software Licensing
The AI-Bio analysis suite and data services.
Service Contracts
Long-term revenue from testing, method development and technical support.
Verifiable Assets
Partnership Models
R&D Collaboration
Joint development with industry or research partners on specific technology directions, with shared IP or per-project settlement.
Technology Licensing
Licensing of instruments, software and evaluation methods, plus regional or vertical channel partnerships.
Investment Opportunity
For strategic and financial investors. Business materials, financial models and due-diligence support available.
Join the Bioavailability Revolution
R&D collaboration · Technology licensing · Investment opportunity — three routes, one business.